Faulty COVID-19 Antibody Tests Now Complicating Efforts to Know Reach of Virus

Back in March, the Food and Drug Administration took the unprecedented step of allowing COVID antibody tests to flood the market without review. The tests were billed as a critical tool to assess where the virus had spread and who might have immunity. But in the government’s rush to get more people tested quickly, it may have missed the mark. Over the course of a three-month investigation, 60 Minutes has learned that federal officials knew that many of the antibody tests were seriously flawed but continued to allow them to be sold anyway.

Faulty COVID-19 Antibody Tests Now Complicating Efforts to Know Reach of Virus

Print Friendly, PDF & Email
Facebooktwitterredditpinterestlinkedinmail

Leave a Reply

You must be logged in to post a comment.